Back pain and spine disease have two common problems causing back pain, degenerative disk disease and facet arthropathy (a type of arthritis). Not all disk problems are amenable to regenerative therapy and patient selection is very important to optimize outcomes. Many forms of back pain are actually due to arthritis of the facet joints (small joints where vertebra connect to their adjacent neighboring vertebrae).
One of the most common causes of back pain is damage to the intervertebral discs (IVDs), soft tissue structures that sit between the vertebrae and act as the spine’s built-in shock absorbers, protecting the bones from the effects of compression and torsion. A normal disc consists of a tough annulus fibrosis, like a motorcycle tire, surrounding a soft, gelatinous center, the nucleus pulposus. Healthy IVDs are remarkably resilient but, as people age, their discs become less effective at producing the water-binding proteoglycans that give them their unique cushioning qualities and they begin to degrade. Stress and trauma can further produce tears in the annulus, allowing the nucleus to bulge, impinging on nerves, and leak irritant substances that cause nerve pain and spasm.
Back Pain and Spine Disease – Gulf Coast Stem Cell & Regenerative Medicine Center
Our Cell Surgical Network(CSN) has developed a back arthritis and spine disease protocol that attempts to exploit the anti-inflammatory and healing effects of SVF (rich in mesenchymal stem cells and growth factors). The protocol uses an advanced method of target planning using MRI with gadolinium contrast to identify inflamed or degenerated areas along the spine. Once these are located, SVF is deployed by laser-guided CAT scan to within 1mm of the targets seen on MRI. This is all done as an outpatient at the time of SVF harvesting and procurement. The entire procedure takes approximately 4 hours. This unique targeting and deployment system is the only one like it in the world for deploying SVF into backs.
In addition, at Gulf Coast Stem Cell & Regenerative Medicine Center(GCSC&RMC,) we have pioneered the incorporation of Extracorporeal Pressure Activation Technology (EPAT) into our protocol of stem cell deployment. This breakthrough modality, first pioneered by STORZ of Germany and Switzerland in 1980 to fragment kidney stones, causes mechanical-chemical transduction, which activates dormant local stem cells and repair processes, producing various active substances. These include substance P that alleviates pain and other complex molecules that activate the healing cascade and attracts more of the deployed stem cells to the site of injury or disease.
We care about our back pain and spine disease patients at GCSC&RMC and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out the Contact Form to the right, we will answer the questions and concerns you may have about GCSC&RMC protocols for back pain and spine disease.